Literature DB >> 3471601

Alterations of MCF-7 human breast cancer cell after prostaglandins PGA1 and PGF2 alpha treatment.

N A Shahabi, N Chegini, J L Wittliff.   

Abstract

Treatment of monolayer cultures of MCF-7 cells with prostaglandins PGA1 and PGF2 alpha inhibited cell proliferation, reduced the rate of labeled precursor incorporation into DNA, RNA, and protein, and induced morphological changes in a dose-dependent manner. The rate of [3H]thymidine incorporation was increased by PGA1 at 10(-10)-10(-8) M, while a sharp decrease was observed at 10(-6)-10(-4) M (p less than 0.05 and p less than 0.005). PGF2 alpha inhibited [3H]thymidine incorporation at all concentrations tested. Similar results were obtained for [3H]uridine incorporation with both PGs. PGA1 inhibited [3H]leucine incorporation at 10(-4) M, but increased incorporation at 10(-10)-10(-6) M. At the ultrastructural level, neither PG induced morphological alterations at 10(-12)-10(-8) M. However, at 10(-6)-10(-4) M both PGA1 and PGF2 alpha diminished the number and size of cell surface projections; some cells appeared to completely lack microvilli. Disorganization of mitochondrial cristae and increased electron density of the matrix were also evident.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3471601

Source DB:  PubMed          Journal:  Exp Cell Biol        ISSN: 0304-3568


  4 in total

1.  The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J2 binds to and activates H-Ras.

Authors:  Jose Luis Oliva; Dolores Pérez-Sala; Antonio Castrillo; Natalia Martínez; F Javier Cañada; Lisardo Boscá; José M Rojas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-08       Impact factor: 11.205

2.  Prostaglandin E2 enhances, and leukotriene C4 inhibits, interleukin-1 inhibition of WEHI-3B cell growth.

Authors:  G R Elliott; C Tak; I L Bonta
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Alkylation of the tumor suppressor PTEN activates Akt and β-catenin signaling: a mechanism linking inflammation and oxidative stress with cancer.

Authors:  Tracy M Covey; Kornelia Edes; Gary S Coombs; David M Virshup; Frank A Fitzpatrick
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

4.  Growth inhibition of Friend erythroleukaemia cell tumours in vivo by a synthetic analogue of prostaglandin A: an action independent of natural killer-activity.

Authors:  S Marini; A T Palamara; E Garaci; M G Santoro
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.